HCPCS Q2035: Influenza Vaccine (Afluria), IM, Age 3+
HCPCS Level II code Q2035 describes the influenza virus vaccine, split virus formulation (Afluria) for intramuscular administration in individuals aged 3 years and older; this represents a single-dose injectable vaccine product used for preventive immunization against seasonal influenza, typically provided in outpatient clinic, physician office, pharmacy, or community vaccination settings as a routine immunization service.
For related coverage guidance, see recent payer policy updates: Truvada (Emtricitabine and Tenofovir Disoproxil Fumarate) for HIV Prevention and Treatment, HIV/AIDS Pharmacologic Prevention and Treatment, Long-Acting Injectable Antiretroviral Agents for HIV.
Customize your policy alerts
Sign up for hcpcs Q2035 policy alerts
Get alerted when payer policies referencing Q2035 are released or updated.
Monitor payer policy activity